Mark Becker

Comparison of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection

Gregory K. Robbins, Victor De Gruttola, Robert W. Shafer et al. · New England Journal of Medicine · 2003 · 354 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Combination Therapy with Efavirenz, Nelfinavir, and Nucleoside Reverse-Transcriptase Inhibitors in Children Infected with Human Immunodeficiency Virus Type 1

Stuart E. Starr, Courtney V. Fletcher, Stephen A. Spector et al. · New England Journal of Medicine · 1999 · 211 citations · Full text

Pharmacy, Pediatrics, Pharmacotherapy +17

Novel Four‐Drug Salvage Treatment Regimens after Failure of a Human Immunodeficiency Virus Type 1 Protease Inhibitor–Containing Regimen: Antiviral Activity and Correlation of Baseline Phenotypic Drug Susceptibility with Virologic Outcome

Steven G. Deeks, Nicholas S. Hellmann, Robert M. Grant et al. · The Journal of Infectious Diseases · 1999 · 169 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Pharmacokinetics of nelfinavir in human immunodeficiency virus-infected infants

Edmund V. Capparelli, John L. Sullivan, Lynne Mofenson et al. · The Pediatric Infectious Disease Journal · 2001 · 38 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Effects of nelfinavir and its M8 metabolite on lymphocyte P‐glycoprotein activity during antiretroviral therapy

John P. Donahue, David W. Dowdy, Krishna K. Ratnam et al. · Clinical Pharmacology & Therapeutics · 2003 · 25 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13